Testing a Smart Medication Dispenser (Mobili®) to Help People With Chronic Conditions Take Their Medicine

Medication adherence is one of the biggest challenges faced by healthcare systems, especially among people with multiple chronic diseases who take several medications daily. Studies show that up to half of patients do not take their medication as prescribed, which can compromise treatment effectiveness, increase complications, and lead to waste of healthcare resources. In this context, several solutions have been developed to help patients organize their therapy, such as dose administration aids (DAAs) used in pharmacies. However, many of these systems are manual, inflexible, or difficult to use. This study is part of the MobiMAd@PT project, which will evaluate Mobili®, a portable digital medication dispenser developed in Norway. Mobili® allows patients to automatically receive the right medication at the right time and comes with a real-time monitoring system, enabling healthcare professionals to detect missed doses and provide timely support. The main goal of this study is to assess the effectiveness of Mobili® in improving medication adherence among patients with polypharmacy in Portugal and to understand whether this type of technology can be useful and applicable in the context of Portuguese community pharmacies. Your participation will contribute to the development of new ways to manage health at home, with the support of pharmacists and technology.

NCT Number	NCT07175545
Lead Sponsor	Lusofona University Collaborators: CBIOS - Research Center for Biosciences & Health Technologies, MedThings, Associação Nacional das Farmácias, University of Oslo, Universidade de Trás-os-Montes e Alto Douro, GHTM - Global Health and Tropical Medicine, COFAC Cooperativa de Formacao e Animacao Cultural CRL (Portugal)
Conditions	Dose Administration Aids, Medication Adherence, Polypharmacy, Technology in Health, Diabetes, Cardiovascular Diseases
Enrollment	96 participants
Start Date	2025-10-15
Primary Completion	2026-04-15 (estimated)
Study Completion	2026-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-09-16